Christopher Murray
Chief Tech/Sci/R&D Officer bij BLUEPRINT MEDICINES CORPORATION
Vermogen: 3 M $ op 31-03-2024
Profiel
Christopher K.
Murray is currently the Chief Technical Operations & Quality Officer at Blueprint Medicines Corp.
Prior to this, he worked at ARIAD Pharmaceuticals, Inc. for 13 years, where he held the position of Vice President-Technical Operations from 2013 to 2017.
Murray received his undergraduate degree from Hope College in 1984 and his graduate degree from The University of Chicago in 1990.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-03-2024 | 33 853 ( 0.06% ) | 3 M $ | 31-03-2024 |
Actieve functies van Christopher Murray
| Bedrijven | Functie | Begin |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 10-10-2017 |
Eerdere bekende functies van Christopher Murray
| Bedrijven | Functie | Einde |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2017 |
Opleiding van Christopher Murray
| Hope College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
